Pages that link to "Q36580487"
Jump to navigation
Jump to search
The following pages link to Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression (Q36580487):
Displaying 15 items.
- Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge (Q33941033) (← links)
- Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis (Q34170655) (← links)
- An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes (Q34987062) (← links)
- CCR5: From Natural Resistance to a New Anti-HIV Strategy (Q35260605) (← links)
- Mortality Trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004) (Q35452217) (← links)
- How HIV changes its tropism: evolution and adaptation? (Q37230002) (← links)
- HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells (Q37287774) (← links)
- Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission (Q37833361) (← links)
- Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance (Q39471859) (← links)
- Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function (Q39725329) (← links)
- The co-receptor signaling model of HIV-1 pathogenesis in peripheral CD4 T cells (Q41975845) (← links)
- Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency. (Q42600049) (← links)
- Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection (Q43480510) (← links)
- Mycobacteria-infected bystander macrophages trigger maturation of dendritic cells and enhance their ability to mediate HIV transinfection (Q43776748) (← links)
- Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge (Q48073666) (← links)